Preferred Label : cilastatin sodium;
UMLS semantic type : T119 - Lipid; T121 - Pharmacologic Substance;
CAS number : 81129-83-1; 5428WXZ74M;
Is substance : O;
UNII : 5428WXZ74M;
InChIKey : QXPBTTUOVWMPJN-QBNHLFMHSA-M;
Origin ID : M0023688;
UMLS CUI : C0282395;
Related record
Semantic type(s)
Validated automatic mappings to NTBT
https://www.has-sante.fr/jcms/p_3259925/fr/recarbrio
2021
false
false
false
France
French
treatment outcome
insurance, health, reimbursement
anti-bacterial agents
infusions, intravenous
drug combinations
imipenem
cilastatin sodium
enterobacteriaceae infections
imipenem, cilastatin and relebactam
evaluation of the transparency committee
relebactam
cilastatin
azabicyclo compounds
imipenem, cilastatin and relebactam
---
https://www.has-sante.fr/portail/jcms/c_2877311/fr/imipenem/cilastatine-gerda
2018
false
false
false
France
drug combinations
imipenem
cilastatin sodium
drugs, generic
evaluation of the transparency committee
cilastatin
---
http://www.has-sante.fr/portail/jcms/c_2628635/fr/tienam
2016
true
France
French
antibiotic therapy
complicated skin and soft tissue infection
drug combinations
infusions, intravenous
cilastatin sodium
cilastatin
imipenem
imipenem and cilastatin
anti-bacterial agents
protease inhibitors
adult
adolescent
child
intraabdominal infections
pneumonia, bacterial
cross infection
pregnancy complications, infectious
soft tissue infections
skin diseases, infectious
urinary tract infections
bacterial infections
bacterial infections
Cilastatin, Imipenem Drug Combination
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_1296215/tienam
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-09/tienam_05092012_avis__ct_12289.pdf
2012
false
France
French
antibiotic therapy
drug combinations
infusions, intravenous
cilastatin sodium
cilastatin
imipenem
imipenem and cilastatin
anti-bacterial agents
protease inhibitors
adult
adolescent
child
intraabdominal infections
pneumonia
cross infection
pregnancy complications, infectious
soft tissue infections
skin diseases, infectious
urinary tract infections
bacterial infections
bacterial infections
Cilastatin, Imipenem Drug Combination
evaluation of the transparency committee
---